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Abstract
Biofabrication is an evolving research ﬁeld that has recently received signiﬁcant attention. In
particular, the adoption of Biofabrication concepts within the ﬁeld of Tissue Engineering and
RegenerativeMedicine has grown tremendously, and has been accompanied by a growing
inconsistency in terminology. This article aims at clarifying the position of Biofabrication as a research
ﬁeldwith a special focus on its relation to and application for Tissue Engineering andRegenerative
Medicine.Within this context, we propose a reﬁnedworking deﬁnition of Biofabrication, including
Bioprinting andBioassembly as complementary strategies within Biofabrication.
Introduction
Biofabrication is a rapidly growing ﬁeld of research
that continues to develop and is outgrowing its
infancy. This is partially due to the expiration of
patents covering fused depositionmodeling [1], which
has rapidly made Additive Manufacturing equipment,
commonly known as three-dimensional (3D)-print-
ing, more affordable and widely available. In concert
with this lowered cost of equipment has been the
transformation of rapid prototyping into rapid manu-
facturing [2]. Additive Manufacturing methods have
also made rapid advances and are now used for the
production of high value parts with complex geome-
tries, such as fuel nozzles in gas turbines, and also for
low number serial production in medical engineering,
as exempliﬁed by the recently FDA approved titanium
hip implant components. A similar evolution and
expansion of applications has occurred in Biofabrica-
tion especially for the ﬁelds of Tissue Engineering (TE)
and Regenerative Medicine (RM). The journal Biofab-
rication was founded in 2009 at the beginning of this
transition, and these developments have led to the
journal recently further clarifying its scope [3].
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This article aims to survey the history of the term
Biofabrication and its different deﬁnitions and uses as
recorded in the literature to date. More importantly,
we believe there is a need to clarify the position of Bio-
fabrication as a research ﬁeld with a special focus on its
relation to and application for TE and RM.Within this
context, we propose a reﬁned working deﬁnition of
Biofabrication, including Bioprinting and Bioassem-
bly as complementary strategies within Biofabrication.
Biofabrication across scientiﬁc disciplines
To our knowledge, the term Biofabrication was ﬁrst
coined in 1994 in relation to the biomineralisation of
pearls [4] and later, in 2003, also the deposition of
enamel in mammalian teeth [5]. In addition, the US
Defence Advanced Research Projects Agency used the
deﬁnition ‘Biofabrication—the use of biological materi-
als and mechanisms for construction’ to describe
methods used to create high-resolution 3D structures
that mimic biological growth mechanisms [6]. In
2004, Biofabrication was used by Payne and co-work-
ers to describe the generation of nanostructured
assemblies containing biological materials and/or
biocatalysts. In their words, they used a rather broad
deﬁnition: ‘the marriage between biology and micro-
fabrication’ [7]. Today, the term Biofabrication is
broadly used in the context of fabricating organic/
inorganic hybrid materials or, more generally, fabrica-
tion of materials [8, 9] by living organisms. Within the
TE and RM community, the term Biofabrication
emerged with the application of 3D manufacturing
strategies incorporating the manipulation and posi-
tioning of living cells and/or cell aggregates. This will
be discussed inmore detail in the subsequent section.
Clearly, the term Biofabrication is currently used
by many scientiﬁc communities and disciplines to
describe different processes and phenomena. There
have been a number of attempts to formulate a broad
deﬁnition of Biofabrication that would embrace its use
within these disparate ﬁelds. Luo, for example, stated
that ‘Regardless of the slight emphasis of the deﬁnitions,
there are several unique features of Biofabrication: ﬁrst,
the building blocks are cells or biologics; second, the fabri-
cation processes are bio-inspired or bio-friendly; and
ﬁnally, the products are biological systems, models or
devices with transformative properties’ [10]. This deﬁni-
tion does not, however, include biological processes
such as biomineralisation, because these are not bio-
inspired but naturally occurring processes. Hence,
since Biofabrication inherently fabricates a product, it
could broadly be described as ‘a process that results in a
deﬁned product with biological function’. This would
encompass all the different and novel aspects of Bio-
fabrication, however it would also include several
otherﬁelds of research and natural processes.
Biofabrication technologies for TE andRM
applications
Herewe focus on the technology of Biofabrication that
uses cells and materials as building blocks, and which
is mainly used for TE and RM applications. Our
objective is to summarize, specify and classify the
rapidly growing and diverging Biofabrication research
activities in the ﬁeld. The use of printing technologies
for 3D positioning of cells was ﬁrst demonstrated in
1988 by Klebe under the term cytoscribing [11].
Despite the truly pioneering character of this work and
possibly because there was a long interval before
researchers returned to the concept, this term was not
picked up by the subsequent literature. The term
‘organ printing’, on the other hand, ﬁrst appeared in
2003 and was deﬁned as ‘a rapid prototyping computer-
aided 3D printing technology, based on using layer-by-
layer deposition of cells and/or cell aggregates into a 3D
gel with sequential maturation of the printed construct
into perfused and vascularized living tissue or organs’
[12]. ‘Organ printing’ is still frequently used, particu-
larly in the popular literature, however its current
usage is often broader than this quite narrow original
deﬁnition.
The historical evolution of the term Biofabrica-
tion, when used in the ﬁeld of TE and RM, has occur-
red in parallel with the evolution of the term
Bioprinting and possibly this has led to a confusion
and possible conﬂation of the two terms, especially in
the popular and journalistic media. Bioprinting was,
to the best of our knowledge, ﬁrst used as a term in the
title of the ‘Workshop on Bioprinting, Biopatterning and
Bioassembly’ held at theUniversity ofManchester, UK,
in 2004. In a report on this meetingMironov, Reis and
Derby stated: ‘For the purpose of the meeting, Bioprint-
ing was deﬁned as: The use of material transfer processes
for patterning and assembling biologically relevantmate-
rials—molecules, cells, tissues, and biodegradable bioma-
terials—with a prescribed organization to accomplish
one or more biological functions’ [13]. The term Bio-
printing was subsequently used to speciﬁcally describe
a process where a mechanical fabrication tool is used
to organize or pattern biological entities in two- or
three-dimensions to build an artiﬁcial construct [14].
In 2010 Guillemot et al deﬁned Bioprinting as ‘the use
of computer-aided transfer processes for patterning and
assembling living and non-living materials with a pre-
scribed 2D or 3D organization in order to produce bio-
engineered structures serving in regenerative medicine,
pharmacokinetic and basic cell biology studies’ [15]. It is
thus clearly related to the parallel development of
Additive Manufacturing that was then emerging as an
engineering fabrication tool. Consequently, Biofabri-
cation was ﬁrst deﬁned byMironov et al in the inaugu-
ral issue of the journal Biofabrication in 2009 as ‘the
production of complex living and non-living biological
products from raw materials such as living cells, mole-
cules, extracellularmatrices, and biomaterials’ [16].
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It is evident that the terms Bioprinting and Biofab-
rication are closely related, and since their respective
existing deﬁnitions overlap, it is extremely difﬁcult to
effectively differentiate them. As a consequence, they
are often used inconsistently or interchangeably,
which underscores the need for clariﬁcation. As
recently pointed out by Hutmacher and colleagues
[17, 18], it would be beneﬁcial for a new ASTM/ISO
norm to be developed, or for a new sub-norm to be
deﬁned under ASTM F2792 in order to unambigu-
ously deﬁne the terms Biofabrication and Bioprinting.
Beyond this more technical approach, and as already
suggested by Boland andMironov [19], we believe that
determining the positioning of Biofabrication as a
research ﬁeld and its relationship with TE and RMwill
help in clarifying these deﬁnitions.
Biofabrication and its relation to TE
andRM
TEwas deﬁned in 1993 as ‘an interdisciplinary ﬁeld that
applies the principles of engineering and life sciences
towards the development of biological substitutes that
restore, maintain, or improve biological tissue function or
a whole organ’ [20]. The ﬁeld of TE has grown and
expanded since 1993, and its deﬁnition has been
extended accordingly. In 2007, for example, 12 federal
agencies in the US proposed a combined deﬁnition of
Tissue Science and TE as: ‘The use of physical, chemical,
biological, and engineering processes to control and direct
the aggregate behavior of cells’ [22]. More importantly,
the ﬁeld of RM has been deﬁned as ‘the application of
tissue science, tissue engineering, and related biological
and engineering principles that restore the structure and
function of damaged tissues and organs’ [23]. This
includes not only in vivo but also in vitro generation of
functional tissue analogues for various purposes such
as drug testing, disease models, including cell/tissue/
organ-on-a-chip approaches. Within TE and RM,
Biofabrication provides a core and vital technology for
these emerging applications that is not restricted
simply to Additive Manufacturing approaches
(ﬁgure 1).
With the classical TE approach, cells are seeded
onto a prefabricated scaffold, typically in conjunction
with the delivery of bioactive factors that ensuremain-
tenance of cellular phenotype and appropriate extra-
cellular matrix formation. This is achieved through
in vitro maturation followed by subsequent implant-
ation, with the aim to functionally regenerate tissue
(ﬁgure 2). An alternative concept envisions the devel-
opment of in vitro 3D tissue models, that exhibit func-
tional features of native tissues, for application in an
in vitro testing or screening system. A more recent
approach, in line with the strategy of RM, is so-called
in situ TE or in situ tissue regeneration, which omits
in vitro cell culture and/or in vitro tissue maturation
steps. This approach aims instead to design materials
and/or exploit the use of chemokines to recruit resi-
dent (stem-) cells to the scaffold and modulate the
local immune response, inducing regenerative
mechanisms in situ [21]. It is within this context that
Additive Manufacturing has been, and still is, used to
generate biomedical implants and scaffolds for seed-
ingwith cells in a classical TE approach.
From a research strategy perspective, Biofabrica-
tion within TE and RM aims at exploiting automated
processes, for the most part Additive Manufacturing
techniques, to generate cell-biomaterial constructs
that, through their internal and external spatial
arrangement may mature into functional tissue
equivalents. Accordingly, these strategies typically tar-
get the development of scaffolds or composite
Figure 1. Schematic venn diagram illustrating the interrelation between Biofabrication, AdditiveManufacturing, and the relatedﬁelds
of Tissue Engineering (TE) andRegenerativeMedicine (RM). Size of the areas and the overlaps does not represent the scale of the
research ﬁelds.
3
Biofabrication 8 (2016) 013001 JGroll et al
constructs which exhibit tissue mimetic hierarchical
features. Alternatively, these constructs are produced
with a structural organization that induces or mod-
ulates the host response after implantation through
paracrine effects. When living single cells, bioactive
molecules, biomaterials, or cell-aggregates small
enough to be printed are used for fabrication, the
mentioned constructs can be achieved by Bioprinting
as deﬁned earlier [15], which is one of the two main
strategies of Biofabrication. We note that Additive
Manufacturing of 3D scaffolds followed by seeding
with cells complies with this strategy when the sub-
sequentmaturation process yields a structural biologi-
cally functional construct. This can for example be
achieved by the scaffold instructing or inducing the
cells to develop into a tissue mimetic or tissue analo-
gue structure, for example, through distinctive cell
interaction, hierarchical induction of differentiation
or functional evolution of themanufactured scaffold.
An alternative strategy for fabricating such con-
structs is to work with larger pre-formed multicellular
fabrication units in the form of cell aggregates, cell
ﬁbers, cell sheets or more complex structures, such as
organoids or microtissues, comprising cells and their
extracellular matrix. These more complex building
blocks are formed through cell-driven self-organiza-
tion in 3D or lower dimension culture, i.e. through a
bottom-up approach, often through the use of
enabling technologies, such as microfabricated molds
or microﬂuidics, followed by tissue fusion and
maturation. Another possible form of these building
blocks are hybrid cell-material constructs, also refer-
red to as hybrid tissues, for example cell loadedmicro-
gels and microcarrier beads [24–26]. A number of
automated assembly techniques are available for
Biofabrication using these building blocks, which can
be subsumed under the term Bioassembly. Depending
on the size, shape and geometry of the cell-containing
units, Bioassembly encompasses a number ofmethods
including Additive Manufacturing techniques, but
also others, such as textile manufacturing routes like
weaving, winding and knitting when cell ﬁbers are
used as building blocks [27]. Also, classical Additive
Manufacturing of biomaterials can be used to generate
templates for Bioassembly. Thus, Bioassembly as a
secondmajor strategy of Biofabrication can be deﬁned
as ‘the fabrication of hierarchical constructs with a pre-
scribed 2D or 3D organization through automated
assembly of pre-formed cell-containing fabrication units
generated via cell-driven self-organization or through
preparation of hybrid cell-material building blocks, typi-
cally by applying enabling technologies, including micro-
fabricatedmolds ormicroﬂuidics’.
Thus, we consider the general area of Biofabrica-
tion within the context of TE and RM should be dis-
tinguished from its use in the area of natural processes,
such as biomineralisation and be conﬁned to manu-
facturing processes as discussed above. Within this
technology space, we propose that there are two dis-
tinct methodologies that can be distinguished by the
length scale of the minimum fabrication unit (pixel or
voxel). These are ‘Bioprinting’ according to the deﬁni-
tion by Guillemot et al [15] and ‘Bioassembly’. For
Bioprinting, the minimum fabrication unit is down to
molecular level. In the case of Bioassembly, the mini-
mum fabrication units are pre-formed cell containing
building blocks with sizes large enough so that auto-
mated assembly can technologically be achieved.
Figure 2 shows the interrelation between these terms
in a schematic diagram. We note that the aim of
Figure 2.The termBiofabrication is used to describe natural processes such as biomineralization and technological processes in
various disciplines such as catalysis, biotechnology, sensing, synthetic biology, and especially TE andRM. For applicationwithin TE
andRM, Biofabrication can generally be divided into two distinct approaches, Bioprinting andBioassembly.
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Biofabrication is to generate a construct with biologi-
cal function. Hence, in most cases neither Bioprinting
nor Bioassembly fully describe the complete Biofabri-
cation process, which is usually dependent on a
maturation phase for the constructed pre-tissue
assembly to allow it to develop a continuous and
coherent functional structure. This maturation pro-
cess may occur either in vitro with a culture phase—
typically adopting the use of bioreactor technology—
or conceivably in vivo after transplantation.
Taking into account these dynamic and evolving
research activities and developments of different tech-
nological aspects, we suggest the following revised
working deﬁnition of Biofabrication for TE and RM as
‘the automated generation of biologically functional pro-
ducts with structural organization from living cells,
bioactive molecules, biomaterials, cell aggregates such as
micro-tissues, or hybrid cell-material constructs, through
Bioprinting or Bioassembly and subsequent tissue
maturation processes.’
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